The key point is simple: tirzepatide may be powerful, but powerful medications require responsible oversight
Faster weight loss means shorter treatment duration to reach a target, lower total compound consumption, and earlier access to the metabolic health benefits that accompany weight reduction
The SURPASS and SURMOUNT trials demonstrate the effectiveness of tirzepatide in improving glycaemic control and promoting weight loss in obese individuals with and without T2D, approaching levels seen from bariatric surgery
Yes, it may contribute to low blood pressure in some situations
Glucagon-like peptide-1 (GLP-1) agonists, which improve insulin secretion, decrease glucagon secretion, increase satiety (and therefore decrease food intake), and may have beneficial effects on beta-cell function, represent an important addition to treatment options
Too many patients are told their numbers are fine until suddenly they arent